Literature DB >> 15966810

Characterization and quantitation of membrane proteomes using multidimensional MS-based proteomic technologies.

Josip Blonder1, Thomas P Conrads, Timothy D Veenstra.   

Abstract

A major goal of proteomics is to develop methods that enable the systematic characterization of every protein within the cell or particular subcellular proteome using a single analytical platform. Although the equivalent has already been achieved in genomics, reaching this goal in proteomics represents a much greater challenge due to the wide dynamic range of protein expression, numerous post-translational modifications and remarkable physicochemical heterogeneity of proteins. A major analytical challenge has involved developing more effective means for proteome-scale investigations of membrane proteins, whose solubility differs drastically from that of cytoplasmic proteins. Fortunately, rapid progress has increased the ability to characterize this critically important class of proteins on a scale analogous to that of aqueous soluble proteins.

Mesh:

Substances:

Year:  2004        PMID: 15966810     DOI: 10.1586/14789450.1.2.153

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  9 in total

1.  Combined chemical and enzymatic stable isotope labeling for quantitative profiling of detergent-insoluble membrane proteins isolated using Triton X-100 and Brij-96.

Authors:  Josip Blonder; Li-Rong Yu; Galina Radeva; King C Chan; David A Lucas; Timothy J Waybright; Haleem J Issaq; Frances J Sharom; Timothy D Veenstra
Journal:  J Proteome Res       Date:  2006-02       Impact factor: 4.466

2.  Universal sample preparation method for proteome analysis.

Authors:  Jacek R Wiśniewski; Alexandre Zougman; Nagarjuna Nagaraj; Matthias Mann
Journal:  Nat Methods       Date:  2009-04-19       Impact factor: 28.547

3.  Mass spectrometry-based analysis of rat liver and hepatocellular carcinoma Morris hepatoma 7777 plasma membrane proteome.

Authors:  Lulu Cao; James G Clifton; Werner Reutter; Djuro Josic
Journal:  Anal Chem       Date:  2013-08-22       Impact factor: 6.986

4.  Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.

Authors:  Darue A Prieto; Donald J Johann; Bih-Rong Wei; Xiaoying Ye; King C Chan; Dwight V Nissley; R Mark Simpson; Deborah E Citrin; Crystal L Mackall; W Marston Linehan; Josip Blonder
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

Review 5.  Chromatographic benefits of elevated temperature for the proteomic analysis of membrane proteins.

Authors:  Adele R Blackler; Anna E Speers; Christine C Wu
Journal:  Proteomics       Date:  2008-10       Impact factor: 3.984

6.  Optimization of protein solubilization for the analysis of the CD14 human monocyte membrane proteome using LC-MS/MS.

Authors:  Xiaoying Ye; Donald J Johann; Ramin M Hakami; Zhen Xiao; Zhaojing Meng; Robert G Ulrich; Haleem J Issaq; Timothy D Veenstra; Josip Blonder
Journal:  J Proteomics       Date:  2009-08-24       Impact factor: 4.044

Review 7.  Mass spectrometry of membrane proteins: a focus on aquaporins.

Authors:  Kevin L Schey; Angus C Grey; Joshua J Nicklay
Journal:  Biochemistry       Date:  2013-03-13       Impact factor: 3.162

8.  Growth of Acinetobacter baumannii in pellicle enhanced the expression of potential virulence factors.

Authors:  Sara Marti; Yassine Nait Chabane; Stéphane Alexandre; Laurent Coquet; Jordi Vila; Thierry Jouenne; Emmanuelle Dé
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

9.  Comparative proteomics of a model MCF10A-KRasG12V cell line reveals a distinct molecular signature of the KRasG12V cell surface.

Authors:  Xiaoying Ye; King C Chan; Andrew M Waters; Matthew Bess; Adam Harned; Bih-Rong Wei; Jadranka Loncarek; Brian T Luke; Benjamin C Orsburn; Bradley D Hollinger; Robert M Stephens; Rachel Bagni; Alex Martinko; James A Wells; Dwight V Nissley; Frank McCormick; Gordon Whiteley; Josip Blonder
Journal:  Oncotarget       Date:  2016-12-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.